Navigation Links
New Shape-HF Cardiopulmonary Testing System to be on Display at the Heart Failure Society of America 13th Annual Scientific Meeting, September 13-16
Date:9/9/2009

The FDA-approved Shape-HF™ Cardiopulmonary Testing System will be on display at the upcoming Heart Failure Society of America 13th Annual Scientific Meeting, beginning September 13, 2009, in Boston. Given that heart failure accounts for 15 million office visits per year and burdens the healthcare system with costs of more than $30 billion, the Shape-HF™ offers a solution to an unmet clinical need to objectively optimize heart failure therapy.

Minneapolis-St. Paul, MN (PRWEB) September 9, 2009 -- Shape Medical Systems, Inc. will be on hand to display its new medical device, the Shape-HF™ Cardiopulmonary Testing System, at the upcoming Heart Failure Society of America 13th Annual Scientific Meeting, beginning September 13, 2009, in Boston. Given that heart failure accounts for 15 million office visits per year and burdens the healthcare system with costs of more than $30 billion, the Shape-HF™ offers a solution to an unmet clinical need to objectively optimize heart failure therapy.

The Shape-HF™ is a non-invasive medical device that assesses heart-lung interaction and ventilation in patients with chronic heart failure and other cardiopulmonary disease. While gas exchange testing devices have been used for several years to measure cardiopulmonary response to exercise, Shape-HF™ is the first device specifically designed for cardiology. It is FDA-approved, easy to use, easy on the patient, and provides clinically relevant data that is easy to understand, reproducible and immediately useful to a cardiologist.

Cardiologists know that the main symptoms of chronic heart failure--shortness of breath and fatigue on exertion--are difficult to objectively quantify, making assessment of the presence or severity of the condition largely subjective. Measuring patient gas exchange is the best method of assessing patient functional capacity, monitoring their response to therapy and predicting outcome. Shape-HF™ is designed to quantify the severity of dyspnea on exertion and fatigue and evaluate the interaction between the heart, lungs, and other organ systems. This makes it possible to evaluate therapy options for the individual patient and track patient progress. In addition, using the Shape-HF™ to measure changes in patient breathing efficiency as cardiac resynchronization therapy (CRT) settings are adjusted allows physicians to assess the physiological effect of therapy in real time while the patient is exercising at a level consistent with normal daily activity.

In addition to being the first and only device that objectively measures cardiopulmonary gas exchange easily and quickly without undue strain on the patient and in the office setting, Shape-HF™ provides real-time physiological assessment to enable CRT optimization during exercise and is cost-effective and easy to use. According to Shape Medical Systems President and COO Clarence Johnson, "Cost, logistics and the complexity of testing and data interpretation, as well as the significant level of patient discomfort associated with cardiopulmonary exercise testing has limited its utility and deprived physicians and their patients of much needed physiological information. Shape-HF™ overcomes these limitations. It provides objective data to the cardiologist right in the office or clinic. The test is easy on patients and the equipment is intuitive and easy to use."

About the Heart Failure Society of America
The Heart Failure Society of America (HFSA) is a nonprofit educational organization, founded in 1994 as the first organized association of heart failure experts. Today HFSA has over 1,500 members and provides a forum for all those interested in heart function, heart failure research and patient care. The HFSA Annual Scientific Meeting is designed to highlight recent advances in the development of strategies to address the complex epidemiological, clinical and therapeutic issues of heart failure. Additional information on HFSA can be found at www.hfsa.org.

About Shape Medical Systems, Inc.Shape Medical Systems Inc. is a privately held, St. Paul, Minnesota-based medical device company whose core technology lies in the development and commercialization of products for assessing heart/lung interaction and ventilation in chronic heart failure and other cardiopulmonary disease. Shape's clear mission is to develop products that increase the quality of patients' lives by helping doctors quantify shortness of breath, assess patient functional capacity, optimize drug, device and rehabilitation therapy, and monitor patient progress. Shape Medical Systems was founded in 2004 and received FDA market clearance for the Shape-HF™ Cardiopulmonary Testing System in April 2009. The Shape-HF™ System, testing protocols and applications are protected by patent 7,225,022 and other U.S. and foreign patents issued and pending.

###

Read the full story at http://www.prweb.com/releases/Shape-HF/Heart_Failure/prweb2848274.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New Shape-HF™ Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting
2. Florida Cardiologist First in United States to Acquire Innovative Shape-HF Cardiopulmonary Testing System
3. Scienceroll.com on an iPhone Application for Cardiopulmonary Resuscitation Training
4. LSUHSC study finds high-dose HBO2 therapy extends survival window after cardiopulmonary arrest
5. Atrium Initiates Voluntary Recall Action Regarding HYDRAGLIDE(TM) Brand Heparin-Coated Thoracic Drainage Catheters Used for Autotransfusion During Cardiopulmonary Bypass Surgery
6. Kroger Selects WaveSense Diabetes Testing Products
7. Cancer Community Alarmed at CMS Policy Lumping Life-Saving Cancer Therapy With Diagnostic Testing For Major Funding Cuts
8. Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy
9. Confidential Online STD Testing Clinic, getSTDtested.com, Introduces Edu-Tainment for STD Prevention as Social Networking Changes Dating Scene
10. Confidential Online STD Testing Clinic, GetSTDTested.com, Strengthens Partnership With ASHA in the Fight Against STDs
11. Motorola Introduces Innovative Wireless LAN Security Solution for Remote Wireless Security Testing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Shape-HF Cardiopulmonary Testing System to be on Display at the Heart Failure Society of America 13th Annual Scientific Meeting, September 13-16
(Date:2/10/2016)... ... 2016 , ... Compliancy Group LLC is pleased to offer ... the country. The Guard was specifically designed to handle each element required for ... updates, and compliance coaching. , In addition to meeting the compliance needs of ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize ... can leave patients with dental emergencies at risk of losing a tooth or their ... care. , Common dental emergencies include:, , Avulsed or ...
(Date:2/10/2016)... ... February 10, 2016 , ... Dr. ... office is now offering a variety of comprehensive procedures for facial enhancement. The ... facial volume restoration, lip enhancement and nasal reshaping. , As a result, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of ... (ALCA) to conduct a survey that takes a closer look at cases of TBI ... prevalence and causes of TBI among the aging population, and identifies the challenges associated ...
(Date:2/10/2016)... Indianapolis, IN (PRWEB) , ... February 10, 2016 ... ... employee benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its ... and has seven other locations throughout the Southeast, from Orlando to Huntsville and ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016 /PRNewswire/ ... a synergistic confluence of various technologies that ... propositions, previously unavailable. These opportunities create a ... convergence, in turn, drives the development of ... scenario is characterized by technology convergences, which ...
(Date:2/10/2016)... 2016 Mast Therapeutics, Inc. (NYSE ... for sickle cell disease and heart failure, today announced ... units at a price to the public of $0.275 ... the Company,s common stock and one warrant to purchase ... exercise price of $0.42 per share. The warrants are ...
Breaking Medicine Technology: